1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. IO BIOTECH INC

IO Biotech Inc

XNAS: IOBT

Download real time

0.96 0.01 (1.05%)

47.83% Fall from 52W High

58,256 XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
11S
6W
0O
2T
63.2

Market Cap

Below industry Median
-0.7

PE TTM

Negative PE TTM
0.1

PEG TTM

PEG TTM is less than 1
0.9

Price to Book

Below industry Median
-0.3

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for IO Biotech Inc is on 26 Mar 2025 for the purpose of IO Biotech Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for IO Biotech Inc

The latest disclosure was made by Amy Sullivan in IO Biotech Inc where a trade of 10,250 Common Stock done at an average price of $0.8 was reported to US exchanges on Dec. 23, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Amy Sullivan Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.83 per share. 23 Dec 2024 10,250 84,632 - 0.8 8,483 Common Stock
Whittemore Devin Smith General Counsel Purchase of securities on an exchange or from another person at price $ 0.81 per share. 23 Dec 2024 12,000 16,938 - 0.8 9,720 Common Stock
Zocca Mai-Britt Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.81 per share. 23 Dec 2024 12,500 49,891 - 0.8 10,120 Common Stock
Qasim Ahmad Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.85 per share. 23 Dec 2024 31,350 31,350 - 0.8 26,553 Common Stock
Christian Elling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 45,642 45,642 - - Stock Option (Right to Buy)
Heidi Hunter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 45,642 45,642 - - Stock Option (Right to Buy)
Peter Hirth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 45,642 45,642 - - Stock Option (Right to Buy)
Helen Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 45,642 45,642 - - Stock Option (Right to Buy)
Kathleen Sereda Glaub Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 45,642 45,642 - - Stock Option (Right to Buy)
David V. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 45,642 45,642 - - Stock Option (Right to Buy)
Qasim Ahmad Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 280,000 280,000 - - Stock Option (Right to Buy)
Amy Sullivan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 280,000 280,000 - - Stock Option (Right to Buy)
Devin Whittemore Smith General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 185,000 185,000 - - Stock Option (Right to Buy)
Brian Burkavage Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 50,000 50,000 - - Stock Option (Right to Buy)
Mai-Britt Zocca Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 750,000 750,000 - - Stock Option (Right to Buy)
Heidi Hunter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2023 64,238 64,238 - - Stock Option (Right to Buy)
Devin Whittemore Smith General Counsel Grant, award, or other acquisition of securities at price $ 1.90 per share. 09 Aug 2023 4,938 4,938 - 1.9 9,382 Common Stock
Mai-Britt Zocca Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.90 per share. 09 Aug 2023 37,037 37,391 - 1.9 70,370 Common Stock
Mai-Britt Zocca Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2023 37,037 37,037 - - Warrants (Right to Buy)
Devin Whittemore Smith General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2023 4,938 4,938 - - Warrants (Right to Buy)
Amy Sullivan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 1.90 per share. 09 Aug 2023 49,382 74,382 - 1.9 93,826 Common Stock
Amy Sullivan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2023 49,382 49,382 - - Warrants (Right to Buy)
Qasim Ahmad Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2023 288,153 288,153 - - Stock Option (Right to Buy)
Christian Elling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 41,533 41,533 - - Stock Option (Right to Buy)
Peter Hirth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 41,533 41,533 - - Stock Option (Right to Buy)
Kathleen Sereda Glaub Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 41,533 41,533 - - Stock Option (Right to Buy)
David V. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 41,533 41,533 - - Stock Option (Right to Buy)
Jack Bech Nielsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 41,533 41,533 - - Stock Option (Right to Buy)
Eva Ehrnrooth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 120,000 120,000 - - Stock Option (Right to Buy)
Mai-Britt Zocca Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 500,000 500,000 - - Stock Option (Right to Buy)
Brian Burkavage Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 50,000 50,000 - - Stock Option (Right to Buy)
Muhammad Al-Hajj Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 120,000 120,000 - - Stock Option (Right to Buy)
Amy Sullivan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 55,000 55,000 - - Stock Option (Right to Buy)
Amy Sullivan Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.32 per share. 17 Mar 2023 25,000 25,000 - 2.3 58,018 Common Stock
Devin Whittemore Smith General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2023 150,000 150,000 - - Stock Option (Right to Buy)
Amy Sullivan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2022 288,152 288,152 - - Stock Option (Right to Buy)
Brian Burkavage Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2022 20,000 20,000 - - Stock Option (Right to Buy)
Jack Bech Nielsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 23,885 23,885 - - Stock Option (Right to Buy)
Christian Elling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 23,885 23,885 - - Stock Option (Right to Buy)
Peter Hirth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 23,885 23,885 - - Stock Option (Right to Buy)
Kathleen Sereda Glaub Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 23,885 23,885 - - Stock Option (Right to Buy)
David V. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 23,885 23,885 - - Stock Option (Right to Buy)
David V. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 28,019 28,019 - - Stock Option (Right to Buy)
Vanessa Malier Director 09 Nov 2021 21,325 0 - - Series C Preferred Stock
Jack B. Nielsen Director 09 Nov 2021 2,365,545 2,365,545 - - Common Stock
Jack B. Nielsen Director Purchase of securities on an exchange or from another person at price $ 14.00 per share. 09 Nov 2021 650,000 3,015,545 - 14 9,100,000 Common Stock
Claus Asbjorn Andersson Director Purchase of securities on an exchange or from another person at price $ 14.00 per share. 09 Nov 2021 75,000 1,791,490 - 14 1,050,000 Common Stock
Claus Asbjorn Andersson Director 09 Nov 2021 354,830 1,716,490 - - Common Stock
Claus Asbjorn Andersson Director 09 Nov 2021 1,361,660 1,361,660 - - Common Stock
Claus Asbjorn Andersson Director 09 Nov 2021 28,225 0 - - Series C Preferred Stock
Claus Asbjorn Andersson Director 09 Nov 2021 147,881 0 - - Series B Preferred Stock
Mai-Britt Zocca Director, Chief Executive Officer 09 Nov 2021 26,580 26,580 - - Common Stock
Mai-Britt Zocca Director, Chief Executive Officer 09 Nov 2021 26,580 0 - - Class A Stock
Vanessa Malier Director Purchase of securities on an exchange or from another person at price $ 14.00 per share. 09 Nov 2021 162,500 958,559 - 14 2,275,000 Common Stock
Vanessa Malier Director 09 Nov 2021 796,059 796,059 - - Common Stock
Vanessa Malier Director Purchase of securities on an exchange or from another person at price $ 14.00 per share. 09 Nov 2021 162,500 430,477 - 14 2,275,000 Common Stock
Vanessa Malier Director 09 Nov 2021 63,350 0 - - Series C Preferred Stock
Vanessa Malier Director 09 Nov 2021 267,977 267,977 - - Common Stock
Jack B. Nielsen Director 09 Nov 2021 188,168 0 - - Series C Preferred Stock
Kathleen Sereda Glaub Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 21,295 21,295 - - Stock Option (Right to Buy)
Mai-Britt Zocca Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 414,212 414,212 - - Stock Option (Right to Buy)
Keith Vendola Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 69,469 69,469 - - Stock Option (Right to Buy)
Peter Hirth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 34,731 34,731 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters